Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q2 2021 Earnings

5MayConfirmed

Q3 2020

Q4 2020

Q1 2021

Q2 2021

-0.54

-0.45

-0.36

-0.27

Details

Expected EPS

-0.51

Actual EPS

-0.42

Surprise EPS

0.09

Surprise Percent

+17.65%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.42 per share for Q2 2021.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.